Views & Analysis | pharmaphorum

Digital

The benefits of adopting a truly digital mindset for pharmac...

Historically, the pharmaceutical industry has been in the laggard phase when it comes to digital adoption.

Digital

The precision element at the heart of digital transformation

On the final day of Reuters Pharma Barcelona back in March, web editor Nicole Raleigh sat down with Graphite Digital’s CEO, Rob Verheul.

Oncology

Sponsored

Sanofi is calling for a comprehensive, UK guideline to impro...

Non-melanoma skin cancer (NMSC) is the most common cancer in the UK, with more than 155,000 cases of NMSC reported in the UK every year.1,2 However, NMSC is significantly under-r

Sales & Marketing

Data & strategy adaptation and adoption in international pha...

How do companies adapt and evolve to different data needs, especially when they are expanding their international presence?

R&D

London, ABPI annual conference, part three

Delivery crucial for UK clinical trials improvement - ABPI a...

The UK Life Sciences Council, a twice-yearly meeting between ministers and global life sciences industry leaders, met on Thursday 25th May to discuss the sector’s economic

Oncology

Sponsored

Sanofi is calling for a comprehensive, UK guideline to impro...

Non-melanoma skin cancer (NMSC) is the most common cancer in the UK, with more than 155,000 cases of NMSC reported in the UK every year.1,2 However, NMSC is significantly under-r

Sales & Marketing

Data & strategy adaptation and adoption in international pha...

How do companies adapt and evolve to different data needs, especially when they are expanding their international presence?

R&D

Delivery crucial for UK clinical trials improvement - ABPI a...

The UK Life Sciences Council, a twice-yearly meeting between ministers and global life sciences industry leaders, met on Thursday 25th May to discuss the sector’s economic

Sales & Marketing

Data & strategy adaptation and adoption in international pha...

How do companies adapt and evolve to different data needs, especially when they are expanding their international presence?

Sales & Marketing

Sponsored

Advancing in the market amidst intensifying competition: How...

As markets become increasingly competitive, pharmaceutical companies must find new ways to differentiate their offerings from others in a therapeutic space.

Digital

The benefits of adopting a truly digital mindset for pharmac...

Historically, the pharmaceutical industry has been in the laggard phase when it comes to digital adoption.

Digital

The precision element at the heart of digital transformation

On the final day of Reuters Pharma Barcelona back in March, web editor Nicole Raleigh sat down with Graphite Digital’s CEO, Rob Verheul.

Market Access

Building a durable and forward-looking pharmaceutical qualit...

Quality culture in the pharmaceutical industry is first and foremost about ensuring products reach patients safely, that they are efficacious, and that they get to the end consumer when exp

Market Access

A new ABPI president; a new take on health, productivity, an...

As the Association of the British Pharmaceutical Industry (ABPI) announces that Susan Rienow, UK managing director and country president of Pfizer, is formally taking on the role of preside

Oncology

Sponsored

Sanofi is calling for a comprehensive, UK guideline to impro...

Non-melanoma skin cancer (NMSC) is the most common cancer in the UK, with more than 155,000 cases of NMSC reported in the UK every year.1,2 However, NMSC is significantly under-r

Oncology

How to optimise delivery of patient support programs in cancer

Sponsored

How to optimise delivery of patient support programmes in ca...

Patient support programmes (PSPs) hold great promise for oncology patients, healthcare professionals, and pharma companies by bridging the gap between clinic and home care.

Oncology

12 Questions with David Long

David Long leads the Oncology Business Unit at MSD in the UK and brings a wealth of experience from his 20 years within the organisation, having held a variety of local, regional and global

Patients

Home

Considering a new standard of care in schizophrenia

As a psychiatrist, I have observed that schizophrenia is a widely known, but poorly understood mental health condition.

Patients

Could virtual wards be the answer to NHS waiting lists?

Hospitals across the UK are under pressure from increasing numbers of admissions year on year and an estimated 7.2 million people – one in eight of England’s population – are on a waiting l

Patients

Improving patient centricity through better relationships be...

The biopharma industry is aiming to deliver more patient-centric decentralised clinical trials (DCTs), and sponsors and sites are focusing on how various models and technologies can help en

R&D

The benefits of adopting a truly digital mindset for pharmac...

The precision element at the heart of digital transformation

Sanofi is calling for a comprehensive, UK guideline to impro...

Data & strategy adaptation and adoption in international pha...

Delivery crucial for UK clinical trials improvement - ABPI a...

Sanofi is calling for a comprehensive, UK guideline to impro...

Data & strategy adaptation and adoption in international pha...

Delivery crucial for UK clinical trials improvement - ABPI a...

Data & strategy adaptation and adoption in international pha...

Advancing in the market amidst intensifying competition: How...

The benefits of adopting a truly digital mindset for pharmac...

The precision element at the heart of digital transformation

Building a durable and forward-looking pharmaceutical qualit...

A new ABPI president; a new take on health, productivity, an...

Sanofi is calling for a comprehensive, UK guideline to impro...

How to optimise delivery of patient support programmes in ca...

12 Questions with David Long

Considering a new standard of care in schizophrenia

Could virtual wards be the answer to NHS waiting lists?

Improving patient centricity through better relationships be...

Health Innovators – Jennifer Schranz

Delivery crucial for UK clinical trials improvement - ABPI a...

How breath analysis could help those living with gut health ...

Parkinson’s wearable matches experts in clinical trial

Inside the new world of healthcare data

Others Old
-About pharmaphorum
-Articles
--eyeforpharma Barcelona 2015
-Audio
-barelonalive 2016
-Cancer
-Diabetes
--Diabetes
-Disease Spotlight
--DMD Main
--LHON Main
-ESMO2016
-ESMO2016-related
-Event coverage
--ASCO-slider
--ASCO-pp
--ASCO-contributor
--ASCO 2018
-Featured content right column
-Featured Event
-Jobs
--pharmaphorum-live
-Medical Affairs Spotlight
--Medical Affairs Spotlight - partner
--Medical Affairs Spotlight - main
-Podcast
-Premium media
-Quintiles
--Quintiles-oncol-PC
--Quintiles - ContentIO
--Quintiles - Articles
--Quintiles - Oncol articles
-Roundtables
--AZ-roundtable-biographies-2017
--AZ-roundtable-interviews-2017
--AZ-roundtable-debate-2017
-Sales and Marketing
--News
--Insights
--Appointments
--Debates
--Debates & Insight
--Views & Analysis
--Partner Content
-Slider in events
-Slider in home page
-Slider in video
-Slider in views and analysis
-Slider in webinars
-Slider in whitepapers
-Spotlight
--Understanding HCPs
--Future of Generics
--Frontiers Health 2022
--Frontiers Health 2021
--Behavioural Science
--ASCO 2019 Live coverage
--AI in Pharma Marketing
--ASCO 2019 and the future of oncology
-Startups
--Views & Analysis
--News
-System
-Top pharmaceutical companies
--Bristol-Myers Squibb
--Teva
--Roche
--Pfizer
--Novo Nordisk
--Novartis
--Merck Inc
--GlaxoSmithKline
--Gilead
--AstraZeneca
--AbbVie
-Top pharmaceutical companies
--Merck Inc
-Top stories
-Transversal Categories
--Brexit
--Clinical
--Digital and Social Media
--US
---Articles
--UK & Europe
--Sales and Marketing
--Rare diseases
--R&D
--Pharma Market Access
--M&A
--Healthcare
-Veeva
-Veeva channel content articles
-Veeva channel content webinars
-Video
-Views and analysis
-Webinars in home page
-Whitepapers
Others
-Transversal Categories
--Sustainability
--Clinical
--Brexit
--Digital and Social Media
--Healthcare
--US
--UK & Europe
--Sales & Marketing
--Rare diseases
--R&D
--Pharma Market Access
--M&A
-Top stories
-About pharmaphorum
-Top pharmaceutical companies
--Gilead
--Merck Inc
--Teva
--Roche
--Pfizer
--Novo Nordisk
--Novartis
--GlaxoSmithKline
--Bristol-Myers Squibb
--AstraZeneca
--AbbVie
-test webinar
-System
-Startups
--News
--Views & Analysis
-Veeva channel content webinars
-Webinars in home page
--Live webinar
--Webinars On demand
-Veeva channel content articles
-Veeva
-Spotlight
-Event coverage
--ASCO-slider
--ASCO-pp
--ASCO-contributor
--ASCO 2018
-ESMO2016-related
-ESMO2016
-Featured Event
-Disease Spotlight
--LHON Main
--DMD Main
-Diabetes
--Diabetes
-Cancer
-barelonalive 2016
-Audio
-Articles
--eyeforpharma Barcelona 2015
-Slider in whitepapers
-Featured content right column
-Jobs
--pharmaphorum-live
-Roundtables
--AZ-roundtable-interviews-2017
--AZ-roundtable-biographies-2017
--AZ-roundtable-debate-2017
-Slider in webinars
-Slider in views and analysis
-Slider in video
-Slider in home page
-Slider in events
-Quintiles
--Quintiles-oncol-PC
--Quintiles - Oncol articles
--Quintiles - ContentIO
--Quintiles - Articles
-Premium media
-Medical Affairs Spotlight
--Medical Affairs Spotlight - partner
--Medical Affairs Spotlight - main
Home
-News
-Views & Analysis
-Deep Dive
-Webinars
--Live webinar
-Podcasts
-Videos
-White Papers
-Events
--JP Morgan
--LSX Investech
--Anthropy
--Reuters Pharma 2022
--World Cancer Series
--Hlth 2022
--PM Society Awards
--Patient Summit PC
--Frontiers Health 2022
--FHlive17
--ASCO 2018
-Digital Debates
-Podcasts & Videos
-Partner Content
--Events
--News
--Appointments
--Press releases
Digital
-Appointments
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Market Access
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Oncology
-Appointments
-Debates
-Insights
-News
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Patients
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
R&D
-Appointments
-Debates
-Debates & Insights
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Partner Content
-Debates & Insight
Sales & Marketing
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Spotlight on
-AI in Pharma Marketing
-ASCO 2019 and the future of oncology
-ASCO 2019 Live coverage
-Behavioural Science
-Frontiers Health 2021
-Frontiers Health 2022
-Future of Generics
-Understanding HCPs
-World Without Disease Summit
-The Future of Generics

Sales & Marketing

Digital

Market Access

Editor's Picks

Oncology

Patients

R&D

Editor's Picks